Abstract
AMP-activated protein kinase (AMPK) is a serine–threonine kinase that functions primarily as a metabolic sensor to coordinate anabolic and catabolic processes in the cell, via phosphorylation of multiple proteins involved in metabolic pathways, aimed to re-establish energy homeostasis at a cell-autonomous level. Myocardial ischemia and reperfusion represents a metabolic stress situation for myocytes. Whether AMPK plays a critical role in the metabolic and functional responses involved in these conditions remains uncertain. In this study, in order to gain a deeper insight into the role of endogenous AMPK activation during myocardial ischemia and reperfusion, we explored the effects of the pharmacological inhibition of AMPK on contractile function rat, contractile reserve, tissue lactate production, tissue ATP content, and cellular viability. For this aim, isolated atria subjected to simulated 75 min ischemia–75 min reperfusion (Is-Rs) in the presence or absence of the pharmacological inhibitor of AMPK (compound C) were used. Since in most clinical situations of ischemia–reperfusion the heart is exposed to high levels of fatty acids, the influence of palmitate present in the incubation medium was also investigated. The present results suggest that AMPK activity significantly increases during Is, remaining activated during Rs. The results support that intrinsic activation of AMPK has functional protective effects in the reperfused atria when glucose is the only available energetic substrate whereas it is deleterious when palmitate is also available. Cellular viability was not affected by either of these conditions.
Similar content being viewed by others
References
Altschuld RA, Wenger WC, Lamka KG, Kindig OR, Capen CC, Mizuhira V, Vander Heide RS, Brierley GP (1985) Structural and functional properties of adult rat heart myocytes lysed with digitonin. J Biol Chem 260:14325–14334
An D, Pulinilkunnil T, Qi D, Ghosh S, Abrahani A, Rodrigues B (2005) The metabolic «switch» AMPK regulates cardiac heparin-releasable lipoprotein lipase. Am J Physiol Endocrinol Metab 288:E246–E253. https://doi.org/10.1152/ajpendo.00211.2004
Baines CP, Wang L, Cohen MV, Downey JM (1998) Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning’s anti-infarct effect in the rabbit heart. J Mol Cell Cardiol 30:383–392. https://doi.org/10.1006/jmcc.1997.0601
Baron SJ, Li J, Russell RR, Neumann D, Miller EJ, Tuerk R, Wallimann T, Hurley RL, Witters LA, Young LH (2005) Dual mechanisms regulating AMPK kinase action in the ischemic heart. Circ Res 96:337–345. https://doi.org/10.1161/01.RES.0000155723.53868.d2
Blackshaw JK, Fenwick DC, Beattie AW, Allan DJ (1988) The behaviour of chickens, mice and rats during euthanasia with chloroform, carbon dioxide and ether. Lab Anim 22:67–75
Blättler SM, Rencurel F, Kaufmann MR, Meyer UA (2007) In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase. Proc Natl Acad Sci U S A 104:1045–1050. https://doi.org/10.1073/pnas.0610216104
Blommaart EFC, Krause U, Schellens JPM, Vreeling-Sindelarova H, Meijer AJ (1997) The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem 243:240–246. https://doi.org/10.1111/j.1432-1033.1997.0240a.x
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254. https://doi.org/10.1016/0003-2697(76)90527-3
Bünger R, Mallet RT, Hartman DA (1989) Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure. Eur J Biochem 180:221–233
Burkhoff D, Weiss RG, Schulman SP, Kalil-Filho R, Wannenburg T, Gerstenblith G (1991) Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. Am J Phys 261:H741–H750
Carvajal K, Zarrinpashneh E, Szarszoi O, Joubert F, Athea Y, Mateo P, Gillet B, Vaulont S, Viollet B, Bigard X, Bertrand L, Ventura-Clapier R, JA H (2007) Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion. Am J Physiol Heart Circ Physiol 292:H3136–H3147. https://doi.org/10.1152/ajpheart.00683.2006
Christensen NJ, Videbaek J (1974) Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction. J Clin Invest 54:278–286. https://doi.org/10.1172/JCI107763
Clemens MJ, Bushell M, Jeffrey IW, Pain VM, Morley SJ (2000) Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ 7:603–615. https://doi.org/10.1038/sj.cdd.4400695
Close B, Banister K, Baumans V, Bernoth E-M, Bromage N, Bunyan J, Erhardt W, Flecknell P, Gregory N, Hackbarth H, Morton D, Warwick C (1996) Recommendations for euthanasia of experimental animals: part 1. Lab Anim 30:293–316
Close B, Banister K, Baumans V, Bernoth EM, Bromage N, Bunyan J, Erhardt W, Flecknell P, Gregory N, Hackbarth H, Morton D, Warwick C (1997) Recommendations for euthanasia of experimental animals: part 2. DGXT of the European Commission. Lab Anim 31:1–32. https://doi.org/10.1258/002367797780600297
Darrabie MD, Arciniegas AJL, Mishra R, Bowles DE, Jacobs DO, Santacruz L (2011) AMPK and substrate availability regulate creatine transport in cultured cardiomyocytes. Am J Physiol Endocrinol Metab 300:E870–E876. https://doi.org/10.1152/ajpendo.00554.2010
Dennis SC, Gevers W, Opie LH (1991) Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol 23:1077–1086. https://doi.org/10.1016/0022-2828(91)91642-5
Evans RD, Hauton D (2016) The role of triacylglycerol in cardiac energy provision. Biochim Biophys Acta Mol Cell Biol Lipids 1861:1481–1491. https://doi.org/10.1016/j.bbalip.2016.03.010
Garland PB, Randle PJ, Newsholme EA (1963) Citrate as an intermediary in the inhibition of phosphofructokinase in rat heart muscle by fatty acids, ketone bodies, pyruvate, diabetes and starvation. Nature 200:169–170. https://doi.org/10.1038/200169a0
Gingras A-C, Raught B, Sonenberg N (1999) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913–963. https://doi.org/10.1146/annurev.biochem.68.1.913
Golomb E, Schneider A, Houminer E, Dunnick J, Kissling G, Borman JB, Nyska A, Schwalb H (2007) occult cardiotoxicity: subtoxic dosage of bis(2-chloroethoxy)methane impairs cardiac response to simulated ischemic injury. Toxicol Pathol 35:383–387. https://doi.org/10.1080/01926230701230338
Green C (1987) Euthanasia. In: Tuffery AA (ed) Laboratory animals: an introduction for new experimenters. Wiley, Chichester, UK
Halse R, Fryer L, McCormack JD (2003) Regulation of glycogen synthase by glucose and glycogen. Diabetes 52:9–15
Handa N, Takagi T, Saijo S, Kishishita S, Takaya D, Toyama M, Terada T, Shirouzu M, Suzuki A, Lee S, Yamauchi T, Okada-Iwabu M, Iwabu M, Kadowaki T, Minokoshi Y, Yokoyama S (2011) Structural basis for compound C inhibition of the human AMP-activated protein kinase2 subunit kinase domain. Acta Crystallogr, Sect D Biol Crystallogr 67:480–487. https://doi.org/10.1107/S0907444911010201
Hardie DG, Ross FA, Hawley SA (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13:251–262. https://doi.org/10.1038/nrm3311
Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271:27879–27887. https://doi.org/10.1074/jbc.271.44.27879
Hearse DJ, Garlick PB, Humphrey SM (1977) Ischemic contracture of the myocardium: Mechanisms and prevention. Am J Cardiol 39:986–993. https://doi.org/10.1016/S0002-9149(77)80212-9
Hermann R, Vélez DE, Rusiecki TM, M de las M FP, Mestre Cordero VE, Marina Prendes MG, Perazzo Rossini JC, Savino EA, Varela A (2015) Effects of 3-methyladenine on isolated left atria subjected to simulated ischaemia-reperfusion. Clin Exp Pharmacol Physiol 42:41–51. https://doi.org/10.1111/1440-1681.12323
Himms-Hagen J, Harper ME (2001) Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp Biol Med 226:78–84
Ilic I, Stankovic I, Vidakovic R, Jovanovic V, Vlahovic Stipac A, Bi P, Neskovic AN (2015) Relationship of ischemic times and left atrial volume and function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Int J Cardiovasc Imaging 31:709–716. https://doi.org/10.1007/s10554-015-0603-4
Kim E-K, Miller I, Aja S, Landree LE, Pinn M, McFadden J, Kuhajda FP, Moran TH, Ronnett GV (2004) C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic amp-activated protein kinase. J Biol Chem 279:19970–19976. https://doi.org/10.1074/jbc.M402165200
King LM, Opie LH (1998) Glucose and glycogen utilisation in myocardial ischemia—changes in metabolism and consequences for the myocyte. Mol Cell Biochem 180:3–26. https://doi.org/10.1023/A:1006870419309
Kingsley PB, Sako EY, Yang MQ, Zimmer SD, Ugurbil K, Foker JE, From AH (1991) Ischemic contracture begins when anaerobic glycolysis stops: a 31P-NMR study of isolated rat hearts. Am J Phys 261:H469–H478
Klevernic IV, Martin NMB, Cohen P (2009) Regulation of the activity and expression of ERK8 by DNA damage. FEBS Lett 583:680–684. https://doi.org/10.1016/j.febslet.2009.01.011
Korvald C, Elvenes OP, Myrmel T (2000) Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol 278:H1345–H1351
Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD (1995) High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270:17513–17520. https://doi.org/10.1074/jbc.270.29.17513
Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS, Lopaschuk GD (1996) Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta Lipids Lipid Metab 1301:67–75. https://doi.org/10.1016/0005-2760(96)00013-6
Kurien VA, Oliver MF (1971) Free fatty acids during acute myocardial infarction. Prog Cardiovasc Dis 13:361–373. https://doi.org/10.1016/S0033-0620(71)80012-9
Lin Y-K, Lai M-S, Chen Y-C, Cheng C-C, Huang J-H, Chen S-A, Chen Y-J, Lin C-I (2012) Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium. Clin Sci 122:121–132. https://doi.org/10.1042/CS20110178
Liu B, el Alaoui-Talibi Z, Clanachan a S, Schulz R, Lopaschuk GD (1996) Uncoupling of contractile function from mitochondrial TCA cycle activity and MVO2 during reperfusion of ischemic hearts. Am J Phys 270:H72–H80
Liu B, Clanachan AS, Schulz R, Lopaschuk GD (1996) Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res 79:940–948. https://doi.org/10.1161/01.RES.79.5.940
Lopaschuk GD (2008) AMP-activated protein kinase control of energy metabolism in the ischemic heart. Int J Obes 32:S29–S35. https://doi.org/10.1038/ijo.2008.120
Lopaschuk GD, Spafford MA, Davies NJ, Wall SR (1990) Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 66:546–553. https://doi.org/10.1161/01.RES.66.2.546
Lopaschuk GD, Collins-Nakai RL, Itoi T (1992) Developmental changes in energy substrate use by the heart. Cardiovasc Res 26:1172–1180. https://doi.org/10.1093/cvr/26.12.1172
Lopaschuk GD, Wambolt RB, Barr RL (1993) An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 264:135–144
Lopaschuk GD, Collins-Nakai R, Olley PM, Montague TJ, McNeil G, Gayle M, Penkoske P, Finegan BA (1994) Plasma fatty acid levels in infants and adults after myocardial ischemia. Am Heart J 128:61–67. https://doi.org/10.1016/0002-8703(94)90010-8
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275. https://doi.org/10.1016/0304-3894(92)87011-4
Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, Hue L (2000) Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 10:1247–1255. https://doi.org/10.1016/S0960-9822(00)00742-9
Mccullough LD, Zeng Z, Liʈ H, Landree LE, Mcfadden J, Ronnettʈ G V (2005) Pharmacological Inhibition of AMP-activated protein kinase provides neuroprotection in stroke*. https://doi.org/10.1074/jbc.M409985200
Momcilovic M, Hong SP, Carlson M (2006) Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 281:25336–25343. https://doi.org/10.1074/jbc.M604399200
Morley SJ, Naegele S (2002) phosphorylation of eukaryotic initiation factor (eif) 4e is not required for de novo protein synthesis following recovery from hypertonic stress in human kidney cells. J Biol Chem 277:32855–32859. https://doi.org/10.1074/jbc.C200376200
Morrison A, Chen L, Wang J, Zhang M, Yang H, Ma Y, Budanov A, Lee JH, Karin M, Li J (2015) Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart. FASEB J 29:408–417. https://doi.org/10.1096/fj.14-258814
Mueller HS, Ayres SM (1980) Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. J Clin Invest 65:338–346. https://doi.org/10.1172/JCI109677
Nichols CG, Lederer WJ (1990) The role of ATP in energy-deprivation contractures in unloaded rat ventricular myocytes. Can J Physiol Pharmacol 68:183–194
Oakhill JS, Steel R, Chen Z-P, Scott JW, Ling N, Tam S, Kemp BE (2011) AMPK is a direct adenylate charge-regulated protein kinase. Science 332:1433–1435. https://doi.org/10.1126/science.1200094
Opie LH (2008) Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia. Circulation 117:2172–2177. https://doi.org/10.1161/CIRCULATIONAHA.108.780999
Pacchia CF, Dosdall DJ, Ranjan R, DiBella E (2014) Alterations in atrial perfusion during atrial fibrillation. Exp Physiol 99:1267–1272. https://doi.org/10.1113/expphysiol.2014.080242
Paiva MA, Gonçalves LM, Providência LA, Davidson SM, Yellon DM, Mocanu MM (2010) Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction. Cardiovasc Drugs Ther 24:25–32. https://doi.org/10.1007/s10557-010-6222-3
Patel MS, Nemeria NS, Furey W, Jordan F (2014) The pyruvate dehydrogenase complexes: Structure-based function and regulation. J Biol Chem 289:16615–16623. https://doi.org/10.1074/jbc.R114.563148
Ping P, Zhang J, Zheng YT, Li RC, Dawn B, Tang XL, Takano H, Balafanova Z, Bolli R (1999) Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res 85:542–550. https://doi.org/10.1161/01.RES.85.6.542
Piper HM, Abdallah Y, Schäfer C (2004) The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61:365–371. https://doi.org/10.1016/j.cardiores.2003.12.012
Ramirez AM, Demeestere K, De Belie N, Mäntylä T, Levänen E (2010) Titanium dioxide coated cementitious materials for air purifying purposes: preparation, characterization and toluene removal potential. Build Environ 45:832–838. https://doi.org/10.1016/j.buildenv.2009.09.003
Randle PJ, Garland PB, Newsholmet EA, Hales CN (1965) The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann N Y Acad Sci 131:324–333. https://doi.org/10.1111/j.1749-6632.1965.tb34800.x
Roche TE, Baker JC, Yan X, Hiromasa Y, Gong X, Peng T, Dong J, Turkan a KS a (2001) Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Prog Nucleic Acid Res Mol Biol 70:33–75. https://doi.org/10.1016/S0079-6603(01)70013-X
Rodríguez-Calvo R, Vázquez-Carrera M, Masana L, Neumann D (2015) AICAR protects against high palmitate/high insulin-induced intramyocellular lipid accumulation and insulin resistance in HL-1 cardiac cells by inducing PPAR-target gene expression. PPAR Res 2015:785783. https://doi.org/10.1155/2015/785783
Russell RR, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH (2004) AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114:495–503. https://doi.org/10.1172/JCI200419297
Saddik M, Lopaschuk GD (1992) Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. J Biol Chem 267:3825–3831
Sambandam N, Lopaschuk GD (2003) AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res 42:238–256. https://doi.org/10.1016/S0163-7827(02)00065-6
Samovski D, Su X, Xu Y, Abumrad NA, Stahl PD (2012) Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a Rab GTPase. J Lipid Res 53:709–717. https://doi.org/10.1194/jlr.M023424
Schrauwen P (2001) An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. FASEB J 15:2497–2502. https://doi.org/10.1096/fj.01-0400hyp
Schwenk RW, Dirkx E, Coumans WA, Bonen A, Klip A, Glatz JFC, Luiken JJFP (2010) Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia 53:2209–2219. https://doi.org/10.1007/s00125-010-1832-7
Shimojo N, Fujino K, Kitahashi S, Nakao M, Naka K, Okuda K (1991) Lactate analyzer with continuous blood sampling for monitoring blood lactate during physical exercise. Clin Chem 37:1978–1980
Solem L (1993) Selective activation of the sodium-independent, cyclosporine A-sensitive calcium pore of cardiac mitochondria by doxorubicin. Toxicol Appl Pharmacol 121:50–57. https://doi.org/10.1006/taap.1993.1128
Stanley WWC, F a R, Lopaschuk GD (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85:1093–1129. https://doi.org/10.1152/physrev.00006.2004
Takagi H, Matsui Y, Hirotani S, Sakoda H, Asano T, Sadoshima J (2007) AMPK mediates autophagy during myocardial ischemia in vivo. Autophagy 3:405–407. https://doi.org/10.4161/auto.4281
Takagi H, Matsui Y, Sadoshima J (2007) The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart. Antioxid Redox Signal 9:1373–1381. https://doi.org/10.1089/ars.2007.1689
Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, Fukunaga R (2004) Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 24:6539–6549. https://doi.org/10.1128/MCB.24.15.6539-6549.2004
Viollet B, Horman S, Leclerc J, Lantier L, Foretz M, Billaud M, Giri S, Andreelli F (2010) AMPK inhibition in health and disease. Crit Rev Biochem Mol Biol 45:276–295. https://doi.org/10.3109/10409238.2010.488215
van der Vusse GJ, Stam H (1987) Lipid and carbohydrate metabolism in the ischaemic heart. Basic Res Cardiol 82(Suppl 1):149–153
Witters LA, Gao G, Kemp BE, Quistorff B (1994) Hepatic 5′-AMP-activated protein kinase: zonal distribution and relationship to acetyl-CoA carboxylase activity in varying nutritional states. Arch Biochem Biophys 308:413–419. https://doi.org/10.1006/abbi.1994.1058
Woods A, Munday MR, Scott J, Yang X, Carlson M, Carling D (1994) Yeast SNF1 is functionally related to mammalian AMP-activated protein kinase and regulates acetyl-CoA carboxylase in vivo. J Biol Chem 269:19509–19515. https://doi.org/10.1073/pnas.051042298
Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LGD, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D (2003) LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13:2004–2008. https://doi.org/10.1016/j.cub.2003.10.031
Woods A, Dickerson K, Heath R, Hong S-P, Momcilovic M, Johnstone SR, Carlson M, Carling D (2005) Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2:21–33. https://doi.org/10.1016/j.cmet.2005.06.005
Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, Saiu P, Howell SA, Aasland R, Martin SR, Carling D, Gamblin SJ (2011) Structure of mammalian AMPK and its regulation by ADP. Nature 472:230–233. https://doi.org/10.1038/nature09932
Xing Y, Musi N, Fujii N, Zou L, Luptak I, Hirshman MF, Goodyear LJ, Tian R (2003) Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative α2 subunit of AMP-activated protein kinase. J Biol Chem 278:28372–28377. https://doi.org/10.1074/jbc.M303521200
Zaha VG, Young LH (2012) AMP-activated protein kinase regulation and biological actions in the heart. Circ Res 111:800–814. https://doi.org/10.1161/CIRCRESAHA.111.255505
Zarrinpashneh E, Carjaval K, Beauloye C, Ginion A, Mateo P, Pouleur A-C, Horman S, Vaulont S, Hoerter J, Viollet B, Hue L, Vanoverschelde J-L, Bertrand L (2006) Role of the 2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. AJP Heart Circ Physiol 291:H2875–H2883. https://doi.org/10.1152/ajpheart.01032.2005
Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167–1174. https://doi.org/10.1172/JCI200113505
Funding
This research was supported by grants from the University of Buenos Aires (UBACyT 20020130100309BA) and the Institute of Drug Chemistry and Metabolism (IQUIMEFA-CONICET).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hermann, R., Mestre Cordero, V.E., Fernández Pazos, M.d.l.M. et al. Differential effects of AMP-activated protein kinase in isolated rat atria subjected to simulated ischemia–reperfusion depending on the energetic substrates available. Pflugers Arch - Eur J Physiol 470, 367–383 (2018). https://doi.org/10.1007/s00424-017-2075-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-017-2075-y